Literature DB >> 25005745

Dynamic RNA modifications in disease.

Arne Klungland1, John Arne Dahl2.   

Abstract

While the presence of 6-methyladenosine (m6A) modifications in mRNA was noted several decades ago, the first enzyme reversing this modification was identified very recently. Today we know of two methyltransferases introducing m6A in mRNA--METTL3 and METTL14--and two demethylases that remove it have been identified-FTO (ALKBH9) and ALKBH5. The conserved role of m6A seems to relate to meiosis, and mice lacking ALKBH5 are infertile. While loss-of-function mutation in FTO causes a recessive lethal syndrome, sequence variants in introns of the FTO gene are associated with obesity and type 2 diabetes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005745     DOI: 10.1016/j.gde.2014.05.006

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  34 in total

Review 1.  Finding the genetic mechanisms of folate deficiency and neural tube defects-Leaving no stone unturned.

Authors:  Kit Sing Au; Tina O Findley; Hope Northrup
Journal:  Am J Med Genet A       Date:  2017-09-25       Impact factor: 2.802

Review 2.  Gene regulation in the immune system by long noncoding RNAs.

Authors:  Y Grace Chen; Ansuman T Satpathy; Howard Y Chang
Journal:  Nat Immunol       Date:  2017-08-22       Impact factor: 25.606

Review 3.  Update: Mechanisms Underlying N6-Methyladenosine Modification of Eukaryotic mRNA.

Authors:  Yang Wang; Jing Crystal Zhao
Journal:  Trends Genet       Date:  2016-10-25       Impact factor: 11.639

Review 4.  RNA biology of angiogenin: Current state and perspectives.

Authors:  Shawn M Lyons; Marta M Fay; Yasutoshi Akiyama; Paul J Anderson; Pavel Ivanov
Journal:  RNA Biol       Date:  2017-02       Impact factor: 4.652

5.  m(6)A-LAIC-seq reveals the census and complexity of the m(6)A epitranscriptome.

Authors:  Benoit Molinie; Jinkai Wang; Kok Seong Lim; Roman Hillebrand; Zhi-Xiang Lu; Nicholas Van Wittenberghe; Benjamin D Howard; Kaveh Daneshvar; Alan C Mullen; Peter Dedon; Yi Xing; Cosmas C Giallourakis
Journal:  Nat Methods       Date:  2016-07-04       Impact factor: 28.547

6.  Subcellular relocalization and nuclear redistribution of the RNA methyltransferases TRMT1 and TRMT1L upon neuronal activation.

Authors:  Nicky Jonkhout; Sonia Cruciani; Helaine Graziele Santos Vieira; Julia Tran; Huanle Liu; Ganqiang Liu; Russell Pickford; Dominik Kaczorowski; Gloria R Franco; Franz Vauti; Noelia Camacho; Seyedeh Sedigheh Abedini; Hossein Najmabadi; Lluís Ribas de Pouplana; Daniel Christ; Nicole Schonrock; John S Mattick; Eva Maria Novoa
Journal:  RNA Biol       Date:  2021-02-15       Impact factor: 4.652

7.  Enhanced detection of post-transcriptional modifications using a mass-exclusion list strategy for RNA modification mapping by LC-MS/MS.

Authors:  Xiaoyu Cao; Patrick A Limbach
Journal:  Anal Chem       Date:  2015-07-28       Impact factor: 6.986

8.  Impact of FTO SNPs rs9930506 and rs9939609 in Prostate Cancer Severity in a Cohort of Puerto Rican Men.

Authors:  Jeannette L Salgado-Montilla; Jorge L Rodríguez-Cabán; Jonathan Sánchez-García; Ricardo Sánchez-Ortiz; Margarita Irizarry-Ramírez
Journal:  Arch Cancer Res       Date:  2017-08-22

9.  Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides.

Authors:  Eikan Mishima; Daisuke Jinno; Yasutoshi Akiyama; Kunihiko Itoh; Shinnosuke Nankumo; Hisato Shima; Koichi Kikuchi; Yoichi Takeuchi; Alaa Elkordy; Takehiro Suzuki; Kuniyasu Niizuma; Sadayoshi Ito; Yoshihisa Tomioka; Takaaki Abe
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

10.  Increased N6-methyladenosine in Human Sperm RNA as a Risk Factor for Asthenozoospermia.

Authors:  Ying Yang; Wei Huang; Jing-Tao Huang; Fan Shen; Jun Xiong; Er-Feng Yuan; Shan-shan Qin; Ming Zhang; Yu-Qi Feng; Bi-Feng Yuan; Song-Mei Liu
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.